Literature DB >> 16525842

The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group.

N G Forouhi1, B Balkau, K Borch-Johnsen, J Dekker, C Glumer, Q Qiao, A Spijkerman, R Stolk, A Tabac, N J Wareham.   

Abstract

The category of IFG was introduced in the late 1990s to denote a state of non-diabetic hyperglycaemia defined by a fasting plasma glucose (FPG) concentration between 6.1 and 6.9 mmol/l. In 2003 the American Diabetes Association recommended that this diagnostic threshold be lowered to 5.6 mmol/l. The justification for lowering the threshold has been questioned. This simple change in cut-off value creates a pandemic of IFG, with a two- to five-fold increase in the prevalence of IFG across the world. Such a change in threshold has far-reaching public health implications. The European Diabetes Epidemiology Group (EDEG) has reviewed the evidence for this lower cut-off point for the definition of IFG and concludes that the previous definition should not be altered. EDEG further recommends that the value of all categorical definitions of non-diabetic hyperglycaemia should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525842     DOI: 10.1007/s00125-006-0189-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Impaired fasting glucose is not a risk factor for atherosclerosis.

Authors:  M Hanefeld; T Temelkova-Kurktschiev; F Schaper; E Henkel; G Siegert; C Koehler
Journal:  Diabet Med       Date:  1999-03       Impact factor: 4.359

2.  Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

Authors:  J E Shaw; P Z Zimmet; M de Courten; G K Dowse; P Chitson; H Gareeboo; F Hemraj; D Fareed; J Tuomilehto; K G Alberti
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

5.  Blood glucose and risk of cardiovascular disease in the Asia Pacific region.

Authors:  C M M Lawes; V Parag; D A Bennett; I Suh; T H Lam; G Whitlock; F Barzi; M Woodward
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

6.  Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose.

Authors:  Jian-Jun Wang; Shen-Yuan Yuan; Liang-Xiang Zhu; Han-Jing Fu; Hong-Bing Li; Gang Hu; Jaakko Tuomilehto
Journal:  Diabetes Res Clin Pract       Date:  2004-11       Impact factor: 5.602

7.  Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.

Authors:  A F G Cicero; A Dormi; S Nascetti; M P Panourgia; E Grandi; S D'Addato; A Gaddi
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

8.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

9.  Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia.

Authors:  Q Qiao; J Lindström; T T Valle; J Tuomilehto
Journal:  Diabet Med       Date:  2003-12       Impact factor: 4.359

10.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

View more
  30 in total

1.  The impact of liver fat vs visceral fat in determining categories of prediabetes.

Authors:  K Kantartzis; J Machann; F Schick; A Fritsche; H-U Häring; N Stefan
Journal:  Diabetologia       Date:  2010-01-23       Impact factor: 10.122

2.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

Review 3.  Prediabetes diagnosis and treatment: A review.

Authors:  Nidhi Bansal
Journal:  World J Diabetes       Date:  2015-03-15

4.  Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study.

Authors:  Bernd Kowall; Wolfgang Rathmann; Klaus Strassburger; Margit Heier; Rolf Holle; Barbara Thorand; Guido Giani; Annette Peters; Christine Meisinger
Journal:  Eur J Epidemiol       Date:  2010-04-06       Impact factor: 8.082

Review 5.  Evidence for current diagnostic criteria of diabetes mellitus.

Authors:  Ritesh Kumar; Lakshmana Perumal Nandhini; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Muthupillai Vivekanadan
Journal:  World J Diabetes       Date:  2016-09-15

6.  The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects.

Authors:  Sang Youl Rhee; Joo Young Kim; Suk Chon; You Cheol Hwang; In Kyung Jeong; Seungjoon Oh; Kyu Jeung Ahn; Ho Yeon Chung; Jeong-Taek Woo; Sung Woon Kim; Jin-Woo Kim; Young Seol Kim
Journal:  Korean Diabetes J       Date:  2010-06-30

7.  Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

Authors:  E Ferrannini; M Massari; M Nannipieri; A Natali; R Lopez Ridaura; C Gonzales-Villalpando
Journal:  Diabetologia       Date:  2009-02-18       Impact factor: 10.122

Review 8.  The Natural Course of Impaired Fasting Glucose.

Authors:  Agnieszka Święcicka-Klama; Katarzyna Połtyn-Zaradna; Andrzej Szuba; Katarzyna Zatońska
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.

Authors:  Prakash Deedwania; Kanan Patel; Gregg C Fonarow; Ravi V Desai; Yan Zhang; Margaret A Feller; Fernando Ovalle; Thomas E Love; Inmaculada B Aban; Marjan Mujib; Mustafa I Ahmed; Stefan D Anker; Ali Ahmed
Journal:  Int J Cardiol       Date:  2013-05-31       Impact factor: 4.164

10.  Prediabetes and the risk of cancer: a meta-analysis.

Authors:  Yi Huang; Xiaoyan Cai; Miaozhen Qiu; Peisong Chen; Hongfeng Tang; Yunzhao Hu; Yuli Huang
Journal:  Diabetologia       Date:  2014-09-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.